CASE STUDY: Filling in the Gaps in the Catalog of Cancer Genes
Dr. Gad Getz and his group at the Broad Institute of MIT and Harvard identifies 33 new cancer-causing genes and finds that the catalog of cancer genes is far from complete. Learn more about the current cancer genome landscape in this Case Study.
Steps Towards Precision Medicine: Utilizing FFPE Specimens for Comprehensive Genomic Characterization
Roy W. Tarnuzzer, Ph.D., the Biospecimen Core Resource Program Manager at the TCGA Program Office, provides an overview of the Formalin-fixed Paraffin Pilot Project, an initiative to investigate best practices for use of FFPE specimens in genomic studies.
TCGA and Its Vital Role in Understanding How Germline Variation Informs the Landscape of Somatic Alterations in Cancer
Dr. Stephen Chanock, M.D., Director of the Division of Cancer Epidemiology & Genetics at the NCI, discusses how TCGA provides a strong foundation for understanding key biological alterations in cancer.
- April 2015
Using TCGA Data to Find a Novel Target for Triple-Negative Breast Cancer
- December 2014
TCGA’s Pan-Cancer Analysis Shows New Possibilities for Classifying Tumors
- June 2014
MTOR Gene Unlocks Two Approaches to Targeted Therapies
- October 2013
Scientists Using TCGA Data Identify 21 Mutational Signatures in Cancer
- June 2013
Analysis Using TCGA Data Identifies New Therapeutic Possibility